App-Quantinova.ai

Consistent Effect of Empagliflozin on Cardiovascular Death in Subgroups by Type of Cardiovascular Disease: Results From EMPA-REG OUTCOME

Silvio E Inzucchi - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Myocardial infarction

BI-10773

Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients With Type 2 Diabetes and Acute Coronary Syndrome: Analysis From Elixa and Importance of Duration of Diabetes

Rhonda Bentley-Lewis - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acute Coronary Syndromes

N/A

Relationship of Kidney Injury Molecule-1 With Estimated Glomerular Filtration Rate and Blood Pressure in the General Population

Stefanie Aeschbacher - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Renal disease

N/A

Statin Use and the Risk of Vascular Events Among Cancer Patients After Radiotherapy to the Thorax, Head and Neck

Jessica Pena - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

Predictors of Diffuse Coronary Artery Disease in an HIV Positive Population

Derek Chew - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

N/A

Trends in the Hospitalization Rates and Outcomes of Patients With Aortic Stenosis From 2004 to 2013

David A Alter - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic stenosis

N/A

The LDL Receptor Genotype Among Patients With Homozygous Familial Hypercholesterolemia is a Significant Determinant of the Rebound Increase in LDL-C Concentrations Following Lipoprotein Apheresis

Andre J Tremblay - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypercholesterolemia, Familial, 1

Dextran sulfate

Oxolipidomic Analysis of Calcific Stenotic Human Aortic Valves: Correlation of Oxidized Phosphatidylcholine and Lysophosphatidic Acid With Aortic Valve Gradient

Aleksandra Stamenkovic - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic stenosis

LT 02

Tube-assisted Feeding is Associated With Worse Longitudinal Growth in Children With Single Ventricle Cardiac Disease

Laura Mercer-Rosa - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypoplastic left heart syndrome

N/A

Organizational Structure, Resources, and Educational Initiatives in Cardiac Intensive Care Units: A National Cross-sectional Survey on Behalf of the American Heart Association Acute Cardiac Care Committee

Zachary Wegermann - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Two-Dimensional Echocardiography Incorrectly Identifies Tricuspid Regurgitation Jet Location Compared to Three-Dimensional Echocardiography in Pre-Operative Assessment of Tricuspid Valve Repair in Hypoplastic Left Heart Syndrome

Billie-Jean Martin - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypoplastic left heart syndrome

N/A

New Metrics of Postoperative Mechanical Ventilation Duration After Congenital Heart Surgery Reveal Variation Across Hospitals

David Werho - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Delayed Staged Palliation Does Not Affect Clinical Outcomes for Children With Hypoplastic Left Heart Syndrome and Variants

Christoph Haller - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypoplastic left heart syndrome

N/A

Increased Cardiac Expression of the Receptor for Advanced Glycation End Products is Associated With Myocardial Apoptosis in Patients Post Coronary Artery Bypass Grafting and in Mice Following Myocardial Infarction

Jean-Francois Desjardins - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Patient and Hospital-level Predictors of Early Unplanned Pediatric Cardiac Intensive Care Unit Readmissions

Vijay Anand - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Investigating Predictors of Rapid Aortic Root Dilation and Referral for Aortic Surgery in Marfan Syndrome

Shaji Menon - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Aortic dilatation

Lorestan

CT-derived Skeletal Muscle Index: A Novel Predictor of Frailty and Hospital Length of Stay After Transcatheter Aortic Valve Replacement

Wayne Batchelor - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Mitral valve regurgitation

N/A

Relationship between the QT Interval and Outcome in Low-Flow Low-Gradient Aortic Stenosis With Low LVEF

Oumhani Toubal - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Cardiac Resynchronization Improves Cardiac Sodium Channel mRNA Splicing Most in Patients With Severe Heart Failure

Anyu Zhou - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemic cardiomyopathy

N/A

Efficacy and Safety of Sacubitril/Valsartan in Patients in NYHA Functional Class IV. An Analysis Of PARADIGM-HF

Jianjian Gong - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

Sacubitril/valsartan

Filters

28841 Abstracts